Patient Guide: Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 86 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04055493
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer Female
Phase: PHASE3

Find a Study Location Near You

This study is available at 86 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Aalen, Baden-Wurttemberg
  • Baden-Baden, Baden-Wurttemberg
  • Böblingen, Baden-Wurttemberg
  • • And 83 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily